Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years (2024)
- Authors:
- USP affiliated authors: BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; FERREIRA, ANA FLAVIA FERNANDES - ICB ; KAMIDAI, NICOLE MIKI - ICB
- Unidade: ICB
- DOI: 10.36922/an.2903
- Subjects: FISIOLOGIA; MODELOS ANIMAIS DE DOENÇAS; ROEDORES; DOENÇAS NEURODEGENERATIVAS; DOENÇA DE PARKINSON
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Advanced in Neurology
- ISSN: 2810-9619
- Volume/Número/Paginação/Ano: v. 3, n. 3, art. 2903, 19 p., 2024
- Status:
- Artigo aberto em periódico híbrido (Hybrid Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
FERREIRA, Ana Flávia Fernandes et al. Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years. Advanced in Neurology, v. 3, n. 3, p. 19 , 2024Tradução . . Disponível em: https://doi.org/10.36922/an.2903. Acesso em: 31 mar. 2026. -
APA
Ferreira, A. F. F., Meira Neta, M. da S., Lemuchi, L. M., Bianchetti, M. E., Kamidai, N. M., Kilinsky, L. M., & Britto, L. R. G. de. (2024). Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years. Advanced in Neurology, 3( 3), 19 . doi:10.36922/an.2903 -
NLM
Ferreira AFF, Meira Neta M da S, Lemuchi LM, Bianchetti ME, Kamidai NM, Kilinsky LM, Britto LRG de. Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years [Internet]. Advanced in Neurology. 2024 ; 3( 3): 19 .[citado 2026 mar. 31 ] Available from: https://doi.org/10.36922/an.2903 -
Vancouver
Ferreira AFF, Meira Neta M da S, Lemuchi LM, Bianchetti ME, Kamidai NM, Kilinsky LM, Britto LRG de. Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years [Internet]. Advanced in Neurology. 2024 ; 3( 3): 19 .[citado 2026 mar. 31 ] Available from: https://doi.org/10.36922/an.2903 - Irisin reduces neurodegeneration and neuroinflammation in the 6-hydroxydopamine rat model of Parkinson’s disease
- Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model
- The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Therapeutic potential of KATP channels in the attenuation of Parkinson's disease pathogenesis and progression: a review
- Mitochondrial abnormalities in neurological disorders
- Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hyydroxydopamine-induced Parkinson’s Disease–Like Pathology
- The role of interleukin-17 in neurological disorders
- Deletion of the transient receptor potential Melastatin 2 gene mitigates the 6-hydroxydopamine-induced parkinson’s disease–like pathology
- Lithium and disease modification: a systematic review and meta-analysis in Alzheimer's and Parkinson’s disease
- Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
